BUB1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, BUB1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated BUB1 data layer compared with 30 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher BUB1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated BUB1 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

LSCC and UCEC are the cancer types where BUB1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LSCCOSTertileII,III,IV1.0000.565.00722view →
UCECDFSTertileII,III,IV0.4761.000.0494view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

BUB1–LSCC (OS)

Kaplan–Meier survival curve for BUB1 mass-spec protein-high vs -low samples in LSCC.

Open the LSCC breakdown →

Exploration